Patents by Inventor Massimo Latino

Massimo Latino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for dissolution testing of solid compositions containing digestive enzymes
    Patent number: 9976171
    Abstract: The invention is directed to a process for measuring the amount of digestive enzymes released from a solid composition in a dissolution medium by fluorescence spectroscopy. The invention is also directed to a combined method for measuring both the dissolution and gastroresistance of a solid compositions comprising pancrelipase.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: May 22, 2018
    Assignee: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
    Inventors: Massimo Latino, Luigi Ghidorsi, Giovanni Ortenzi
  • METHOD FOR DISSOLUTION TESTING OF SOLID COMPOSITIONS CONTAINING DIGESTIVE ENZYMES
    Publication number: 20140295474
    Abstract: The invention is directed to a process for measuring the amount of digestive enzymes released from a solid composition in a dissolution medium by fluorescence spectroscopy. The invention is also directed to a combined method for measuring both the dissolution and gastroresistance of a solid compositions comprising pancrelipase.
    Type: Application
    Filed: August 8, 2012
    Publication date: October 2, 2014
    Applicant: Aptalis Pharma Ltd.
    Inventors: Massimo Latino, Luigi Ghidorsi, Giovanni Ortenzi
  • MICROPELLET COMPOSITIONS COMPRISING PANCREATIN CONTAINING DIGESTIVE ENZYME MIXTURE
    Publication number: 20140127307
    Abstract: The present invention relates to a small particle size composition comprising pancreatin containing digestive enzymes for use in patients in need, including pediatric, geriatric, and adult patients, particularly those patients with dysphagia or wherein enteral administration using such composition would be suitable. In addition, the invention is directed to the composition as particles, such as micropellets or microgranules having a high potency, high useable yield and at least 10%-90% of 400-800 ?m. Furthermore, the composition optionally has an improved enteric coating and concomitant improved stability and enzyme activity compared to conventional prepared enterically coated pancreatic enzyme particles.
    Type: Application
    Filed: November 2, 2012
    Publication date: May 8, 2014
    Applicant: APTALIS PHARMA LIMITED
    Inventors: Gopi M. VENKATESH, Craig Kramer, Flavio Fabiani, Luigi Mapelli, Giovanni Ortenzi, Massimo Latino